drugset / Trial / NCT02203955

Study of Sc-FOS for Pouchitis Prevention

NCT02203955 ↗

Phase 1 Completed 13 enrolled Mayo Clinic
RandomizedParallel-groupTriple-blindPrevention

Summary

The main objective is to compare prebiotic therapy with placebo for the prevention of pouchitis after closure of diverting ileostomy in patients with an ileal pouch anal anastomosis. This study will also characterize the effects of prebiotics on the fecal microbiota and fecal microbial metabolites and correlate these effects with the primary outcome of development of pouchitis.

Timeline

Start
2014-08
Primary completion
2017-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Short-Chain Fructooligosaccharide Unknown 8 g Oral

Indications